Skip to main content
C

CELLUMED CO., LTD. — Investor Relations & Filings

Ticker · 049180 ISIN · KR7049180003 KO Manufacturing
Open in API
Filings indexed 396 across all filing types
Latest filing 2022-02-03 Capital/Financing Update
Country KR South Korea
Listing KO 049180

About CELLUMED CO., LTD.

http://www.clnzyme.co.kr/

CELLUMED CO., LTD. is a biotechnology company specializing in the development and manufacturing of medical devices, tissue grafts, and advanced biologics. The company operates as a human tissue bank, producing and supplying a variety of bone graft materials, including allografts and xenografts, for transplantation. Its medical device portfolio features orthopedic implants, with a key product being an artificial knee joint system. In the biologics sector, Cellumed develops growth factors and provides specialized enzymes, such as CLnZyme, which are utilized in the research, development, and production of RNA-based vaccines and therapeutics.

Recent filings

Filing Released Lang Actions
전환가액의조정(제25회차)
Capital/Financing Update Classification · 1% confidence The document is a formal regulatory filing from the Korea Exchange (KRX) regarding the adjustment of the conversion price for convertible bonds (CB). It details the change in conversion price due to a decline in market price, which directly impacts the company's capital structure and potential share dilution. This falls under the category of capital and financing updates, specifically related to convertible debt instruments.
2022-02-03 Korean
[기재정정]전환가액의조정(제24회차)
Share Issue/Capital Change Classification · 1% confidence The document is a formal regulatory filing regarding the adjustment of the conversion price for convertible bonds (제24회차). It details the change in conversion price and the resulting change in the number of convertible shares due to market price fluctuations. This type of filing is a standard corporate disclosure related to capital structure and financing instruments, which falls under the 'Capital/Financing Update' category.
2022-01-04 Korean
[기재정정]전환가액의조정(제25회차)
Share Issue/Capital Change Classification · 1% confidence The document is a formal regulatory filing regarding the adjustment of the conversion price for convertible bonds (제25회차 전환사채). It details the change in conversion price due to market price fluctuations, which directly impacts the company's capital structure and potential share dilution. This falls under the category of capital and financing updates as it relates to the terms of issued debt instruments.
2022-01-04 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 1% confidence The document is a short regulatory announcement regarding the setting of a record date for a shareholder meeting (the 37th Annual General Meeting). It does not contain the full meeting materials or proxy statements, but rather serves as a formal notice of the record date for shareholder rights. Given it is a regulatory announcement regarding corporate governance procedures that does not fit into specific categories like AGM-R or PSI, it is classified as a general regulatory filing.
2021-12-16 Korean
전환가액의조정(제24회차)
Capital/Financing Update Classification · 1% confidence The document is a formal regulatory filing from the Korea Exchange (KRX) system regarding the adjustment of the conversion price for convertible bonds (CB). It details the change in conversion price, the number of convertible shares, and the underlying reasons (market price decline). This falls under capital structure changes and financing updates, specifically related to convertible debt instruments.
2021-12-01 Korean
전환가액의조정(제25회차)
Capital/Financing Update Classification · 1% confidence The document is a formal regulatory filing from the Korean Exchange (KRX) system regarding the adjustment of the conversion price for convertible bonds (CB). It details the change in conversion price from 6,950 KRW to 6,150 KRW due to a decline in market price. This type of disclosure is a standard capital structure update related to financing instruments. Since it specifically concerns the adjustment of conversion terms for existing debt securities, it falls under the 'Capital/Financing Update' category.
2021-12-01 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.